The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Cohen Fred E since year 2005.
The trader's CIK number is 1339358.
At the time of this reporting, Cohen Fred E is the Director of Biocryst Pharmaceuticals Inc .
(stock ticker symbol BCRX).
See this page for all insider trading activities at Biocryst Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-09-18||BCRX||Biocryst Pharmaceuticals Inc||Option Ex||54,250||4.27||231,647|
|2017-09-18||BCRX||Biocryst Pharmaceuticals Inc||Sale||54,250||5.42||294,035|
|2017-05-19||GHDX||Genomic Health Inc||Option Ex||8,250||14.37||118,552|
|2017-05-19||GHDX||Genomic Health Inc||Sale||8,250||29.55||243,746|
|2017-05-18||GHDX||Genomic Health Inc||Option Ex||16,500||18.05||297,742|
|2017-05-18||GHDX||Genomic Health Inc||Sale||16,500||29.88||493,036|
|2017-05-16||GHDX||Genomic Health Inc||Option Ex||8,250||18.13||149,572|
|2017-05-16||GHDX||Genomic Health Inc||Sale||8,250||30.68||253,101|
|2016-01-11||FPRX||Five Prime Therapeutics Inc||Option Ex||24,695||8.50||209,833|
|2015-01-08||BCRX||Biocryst Pharmaceuticals Inc||Option Ex||100,000||1.29||129,000|
|2012-08-01||GHDX||Genomic Health Inc||Option Ex||8,250||10.73||88,522|
|2008-02-19||GHDX||Genomic Health Inc||Option Ex||5,201||.58||2,995|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cohen Fred E (Director of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.